Wells Fargo Upgrades Tandem Diabetes Care to Overweight, Raises Price Target to $45
Tandem Diabetes Care, Inc. -1.67% Pre
Tandem Diabetes Care, Inc. TNDM | 33.54 33.54 | -1.67% 0.00% Pre |
Wells Fargo analyst Larry Biegelsen upgrades Tandem Diabetes Care (NASDAQ:
TNDM) from Equal-Weight to Overweight and raises the price target from $21 to $45.